Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.

Award Number: R42CA239842
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2019
PERIOD OF PERFORMANCE END DATE: 08/31/2022

Group Awards By:

View Award Description

InheRET: A SaaS solution to identify patients at increased risk for hereditary disease. - PROJECT SUMMARY This project is to expand the InheRET Inherited Risk Evaluation Tool to include recommendations for testing of patients at increased risk for hereditary disease, adding patient navigation features and customizable database entries for healthcare providers. This will include the development, integration and testing of InheRET 3.0 followed by pilot testing in 5 diverse clinics. InheRET's aim is to quickly and easily identify individuals at increased risk for hereditary diseases enabling them to access downstream care, reducing morbidity and mortality. InheRET's unique features reduces clinical ascertainment barriers, streamlines workflows and enhances profitability within health systems. The aims for this project are to complete in silico (computer generated) testing of the cognitive computing engine of InheRET followed retrospective testing and finally, pilot testing in a variety of clinical settings to determine if any additional changes are needed to the product prior to commercialization. In addition, we will expand the integration of the InheRET program with an EPIC electronic health record system, providing hard and/or soft alerts for providers as patient reports become available. Success will be determined if we achieve 100% concordance with the in silico testing (i.e. the cognitive computing engine functions correctly), 98% concordance with clinical determinations in the clinical pilot testing, and 100% concordance in the integration testing (all patient reports are appropriately and seamlessly routed to the proper medical records). Our primary objective is to produce an accurate, easy-to-use and understandable report to ensure patients who may unknowingly harbor inherited genetic mutations are identified, thereby enabling them to access genetic counselors and testing along with appropriate downstream care. While both patient and physician reports are provided, the physician reports will be enhanced by providing recommended genes for testing with streamlined ordering processes. By doing so, patients can reduce their risk of disease, receive tailored treatment if they incur disease, and reduce overall mortality.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2021 ( Subtotal = $1,016,123 )
2021	2021	INHERET, INC	3470 GREENLEAF CT	ANN ARBOR	MI	48105	WASHTENAW	USA	Cancer Cause and Prevention Research	002	3	8/20/2021	NON-COMPETING CONTINUATION	$995,667
2021	2020	INHERET, INC	3470 GREENLEAF CT	ANN ARBOR	MI	48105	WASHTENAW	USA	Cancer Cause and Prevention Research	001	2	4/23/2021	COMPETING CONTINUATION	$20,456
2021	2020	INHERET, INC	1600 HURON PKWY BLDG 520-2341	ANN ARBOR	MI	48109	WASHTENAW	USA	Cancer Cause and Prevention Research	000	2	10/15/2020	COMPETING CONTINUATION	$0
														Subtotal = $1,016,123

Issue Date FY: 2020 ( Subtotal = $993,562 )
2020	2020	INHERET, INC	1600 HURON PKWY BLDG 520-2341	ANN ARBOR	MI	48109	WASHTENAW	USA	Cancer Cause and Prevention Research	000	2	9/10/2020	COMPETING CONTINUATION	$993,562
														Subtotal = $993,562

Grand Total All Awards = $2,009,685

Top

All Categories

About

Search

Reports

Data Submission

Award Information

InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.

Award Number: R42CA239842

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2019

PERIOD OF PERFORMANCE END DATE: 08/31/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer